Samuel J. Reich - Feb 28, 2023 Form 4 Insider Report for SAB Biotherapeutics, Inc. (SABS)

Signature
/s/ Samuel J. Reich
Stock symbol
SABS
Transactions as of
Feb 28, 2023
Transactions value $
$0
Form type
4
Date filed
3/2/2023, 08:18 AM
Previous filing
Sep 15, 2022
Next filing
Mar 16, 2023

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction SABS Warrants Other $0 -209K -100% $0.00* 0 Feb 28, 2023 Common Stock 209K $11.50 Via Big Cypress Holdings LLC F1
transaction SABS Warrants Other $0 +9.97K $0.00 9.97K Feb 28, 2023 Common Stock 9.97K $11.50 Direct F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Pro rata distribution by Big Cypress Holdings LLC to its members for which no consideration is being paid in connection with such distribution. The Reporting Person is a managing member of Big Cypress Holdings LLC, and as part of the distribution received 9,968 warrants of the issuer, which the Reporting Person previously had an indirect pecuniary interest.
F2 The Reporting Person received 9,968 warrants as part of the distribution, which the Reporting Person previously had an indirect pecuniary interest. Therefore, the transaction, which only changes the form of the Reporting Person's ownership without increasing or decreasing his pecuniary interest, is exempt from the reporting requirements of Section 16 pursuant to Rule 16a-13. Notwithstanding, the Reporting Person is reporting the acquisition on a voluntary basis.